Chris Aiken

Join Dr. Chris Aiken, Editor-in-Chief of the Carlat Psychiatry Report and Yale-trained psychiatrist, as he explores the intriguing spectrum of mood disorders. He discusses the distinction between bipolar disorder and manic-depressive illness, the impact of individual temperaments on treatment, and innovative non-pharmacological strategies. Dr. Aiken also delves into the potential of the keto diet and the role of nutrition in mental health. Plus, insights on sleep patterns and their effects on mood make for a compelling conversation!

Dr. Chris Aiken, a prominent psychiatrist and editor-in-chief known for his expertise in psychopharmacology, dives into the world of pharmacogenetics. He discusses essential genetic tests that matter in psychiatric practice, cutting through marketing misconceptions. Learn about vital metabolic tests like CYP2D6, CYP3A4, and the implications of HLA-B*1502 for drug safety. He explains how understanding genetic variability can prevent severe side effects and improve patient outcomes, highlighting real-world applications and FDA requirements.

Chris Aiken, psychiatrist and editor who reviews pharmacogenetic literature, breaks down SERT (SLC6A4) testing and its link to SSRI response. He explains alleles, theoretical mechanisms, and why pharmacodynamic predictions are unreliable. He reviews meta-analyses, population differences, stress-related claims, and offers practical advice on interpreting test results in clinic.

In this discussion, Dr. Chris Aiken, a psychiatrist and assistant professor, dives into the complexities of treating difficult-to-treat depression. He critiques the traditional serotonin model and emphasizes the importance of integrating lifestyle changes and neuroprotective strategies into psychiatric care. The conversation also explores the role of thyroid hormones, methylfolate, and even testosterone supplementation in managing depression. Aiken advocates for personalized treatment approaches, moving beyond the label of 'treatment-resistant' to focus on holistic patient well-being.

Dr. Chris Aiken, a psychiatrist and educator, dives deep into pharmacogenetics-guided dosing. He reveals how understanding whether patients are poor or rapid metabolizers can change treatment outcomes dramatically. Aiken emphasizes tailored dosing strategies: for poor metabolizers, he suggests starting low and going slow, while for rapid metabolizers, targeting higher doses works best. He also discusses the importance of monitoring clinical response and serum levels, highlighting a personalized approach to psychiatric care. A must-listen for mental health professionals!